Ayurvedic medicine AYUSH 64 given to Covid-19 Patients

Covid-19 has been a difficult condition for our country and it has been tiring for our medical professionals. It has been affected by a large population in our country. The vaccines are being produced and delivered but to make them available to a large sum of the population takes time and a lot of effort. At this point, a combination of allopathic and ayurvedic treatments have started to be given to mild and moderate Covid-19 patients. AYUSH-64 is an Ayurvedic formulation that was developed by the Central Council for Research in Ayurvedic Sciences (CCRAS).

Here comes the importance of Ayurveda for the healthy and persistent wellness of our respiratory system. Ayurvedic treatment and medicines use precious and powerful herbs with the help of trusted ayurvedic formulations to create medicines for various respiratory problems. It is rather focused on the causes than the symptoms of various diseases to give long-term relief to the illness. Ayurveda brings health and keeping the doshas in balance. It aims at holistically maintaining and improving general health and boosting the natural immunity of the body. Also, helps reclaim health with balanced dietary guidelines, effective sleeping patterns, daily and seasonal routines, yoga, and exercise patterns.

Who can take AYUSH-64?

It can be taken by patients at any stage of the COVID-19 disease. However, its scientific efficacy was scientifically studied in asymptomatic, mild, and moderate diseases without risk factors for poor outcome and those not requiring emergency interventions or hospitalization are eligible to take Ayush-64. Mild to moderate COVID-19 cases showing initial symptoms like fever, malaise, body ache, nasal congestion, nasal discharge, headache, cough, etc., and asymptomatic cases of COVID-19 can preferably start AYUSH- 64 within 7 days of diagnosis of the disease through RT-PCR for a better outcome.

Is its efficacy on COVID-19 scientifically proven?

AYUSH-64 is a polyherbal formulation developed in compliance with all regulatory requirements and quality and pharmacopeial standards by the Central Council for Research in Ayurvedic Sciences (CCRAS) the apex body for research in Ayurveda under the Ministry of Ayush. It has been scientifically found to be useful in the treatment of asymptomatic, mild and moderate COVID-19 infection as an adjunct to standard care through robust clinical trials conducted in the country. The results of the clinical trials demonstrated that AYUSH-64 as an adjunct to standard of care (SoC) showed clinically significant improvement and thus lesser period of hospitalization as compared to SoC alone.

Ayurveda has been in our country for over 5000 years and has seen many health conditions and illnesses. So, it has natural remedies for all kinds of health problems. Precious herbs and organic substances are mixed in the right proportions with the use of trusted ayurvedic formulations by experts to produce the right medicine for a particular health issue. Bipha Healthcare has over 90 years of experience in Ayurvedic treatment and in producing ayurvedic medicines for various diseases. Bipha Healthcare has also got the license for producing Ayush-64 which gives immediate relief to mild and moderate Covid-19 affected patients. Its production has been started by Bipha Healthcare for distribution. Thus, providing vital help to Covid-19 treatment across our country.

Ayush 64 has been showing good signs of relief from Covid-19 disease at any stage. It is available in the market and can be purchased from Ayurvedic pharmacies. However, it should be ensured that it should not be used as an over-the-counter prescription (OTC) and shall only be used under the supervision of Ayurvedic physicians. Let's unite together with Ayus 64 to eradicate Covid-19 from our country and from the whole world.